Mycobacterium abscessus peritonitis and ventriculitis associated with ventriculoperitoneal shunt

D Clabots1, A Serrat1

  • 1Palmetto General Hospital, 2001 W 68th St, Suite 202, Hialeah, FL 33016, USA.

Idcases
|March 4, 2022
PubMed

Insights

Healthcare-associated Mycobacterium abscessus infections are challenging to treat. A rare case involved a shunt-associated central nervous system infection in a patient with hydrocephalus, highlighting treatment complexities.

Area of Science:

  • Infectious Diseases
  • Neurology
  • Medical Microbiology

Background:

  • Nontuberculous mycobacteria, including Mycobacterium abscessus, are common environmental organisms.
  • Mycobacterium abscessus infections are often healthcare-associated and notoriously difficult to treat.
  • Treatment requires multidrug regimens and prolonged courses due to antibiotic resistance.

Observation:

  • A 39-year-old female with pseudotumor cerebri and a history of ventriculoperitoneal shunt placement presented with neurological symptoms.
  • Following a new shunt placement for hydrocephalus, the patient experienced clinical worsening, including confusion and echolalia.
  • Intraoperative findings revealed viscous secretions on the peritoneal catheter, with cultures positive for Mycobacterium abscessus.

Findings:

  • The cerebrospinal fluid and shunt fluid cultures confirmed Mycobacterium abscessus CNS infection.
  • This case represents a rare instance of shunt-associated central nervous system infection caused by Mycobacterium abscessus.
  • The patient's infection demonstrated characteristics of difficult-to-treat mycobacterial infections.

Implications:

  • Shunt-associated CNS infections with Mycobacterium abscessus are rare and pose significant therapeutic challenges.
  • Inducible macrolide resistance and inherent antibiotic resistance complicate treatment strategies for M. abscessus.
  • This case underscores the need for vigilance and tailored treatment approaches for rare mycobacterial CNS infections.